News Announcement

Marksans Pharma: Unaudited Financial Results For The Third Quarter Ended 31St December 2021 And Limited Review Reports Thereon.

In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the third quarter ended 31st December 2021 which have been approved by the Board of Directors at its meeting held today i.e. 11th February 2022 along with Limited Review Reports given by Statutory auditor of the Company.
The meeting commenced at 12:00 noon and concluded at 12:45 p.m.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds